Compare Global X Autonomous & Electric Vehicles (DRIV) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Autonomous & Electric Vehicles vs Johnson & Johnson — how do they compare? Global X Autonomous & Electric Vehicles trades at $32.76 (market cap $356.37M), while Johnson & Johnson trades at $261.44 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 1734.4× Global X Autonomous & Electric Vehicles's market cap, and Johnson & Johnson pays a 2.09% dividend while Global X Autonomous & Electric Vehicles pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Autonomous & Electric Vehicles for 40 Days and Johnson & Johnson for 129 Days on average.
| DRIV | JNJ | |
|---|---|---|
Market Cap | $356.37M | $618.09B |
Volume | 22,397 | 6,050,983 |
Sector | Sector/Thematic | Health |
52-Week High | $42.53 | $278.43 |
52-Week Low | $27.58 | $186.00 |
Typical Hold Time | 40 Days | 129 Days |
Enterprise Value | — | $646.37B |
Dividend Yield | — | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DRIV trades at $32.79, down 1.72% today amid mixed technical signals. The stock shows a bullish overall technical signal but bearish moving averages, with neutral oscillators suggesting consolidation. Recent automotive sector news highlights hybrid vehicle momentum and China's EV ambitions, potentially impacting this automotive-focused investment.
Investment outlook remains cautious pending fundamental data verification. Key opportunities include exposure to automotive innovation trends, while risks involve sector volatility and reliance on unverified financial metrics. The technical setup suggests near-term consolidation around current levels.
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X Autonomous & Electric Vehicles
DRIV invests in companies involved in autonomous driving and electric vehicle production. It tracks the Solactive Autonomous & Electric Vehicles Index, focusing on software and hardware leaders like Tesla, NVIDIA, and Microsoft.
Read more on DRIV →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
